
RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.
Hot off the press: Three new studies, including one that reports middle-age physically fit women are nearly 90% less likely to develop dementia decades later.